Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kangji Medical Holdings Limited ( (HK:9997) ) has issued an announcement.
Kangji Medical Holdings Limited has announced a delay in the dispatch of its Scheme Document related to its proposed privatization by Knight Bidco Limited through a scheme of arrangement. The delay is due to the need for additional time to fulfill pre-conditions, finalize the Scheme Document, and obtain directions from the Grand Court, which is currently on vacation. The extension has been approved, and the document is now expected to be dispatched by October 31, 2025. This delay may impact the timeline for the company’s privatization and subsequent withdrawal of its listing, potentially affecting stakeholders’ plans and expectations.
The most recent analyst rating on (HK:9997) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Kangji Medical Holdings Limited stock, see the HK:9997 Stock Forecast page.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited operates in the medical industry, focusing on the development and production of minimally invasive surgical instruments and accessories. The company is known for its innovative solutions and caters to a global market, aiming to enhance surgical efficiency and patient outcomes.
Average Trading Volume: 7,223,108
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.25B
Find detailed analytics on 9997 stock on TipRanks’ Stock Analysis page.